Drug Type Small molecule drug |
Synonyms DAT 2000, DAT2000 |
Target |
Action inhibitors |
Mechanism PARG inhibitors(Poly(ADP-ribose) glycohydrolase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Phase 1 | China | - | |
Female Genital Neoplasms | Phase 1 | China | - | |
Gastrointestinal Neoplasms | Preclinical | China | 13 Apr 2023 |